Clinical Trials Logo

Filter by:
NCT ID: NCT06262191 Active, not recruiting - Cerebral Palsy Clinical Trials

Testing an Adjustable Ankle Orthosis During Walking in Cerebral Palsy

Start date: May 1, 2024
Phase: Early Phase 1
Study type: Interventional

This study seeks to determine how an adjustable stiffness ankle braces affects walking performance and biomechanics in cerebral palsy.

NCT ID: NCT06262139 Not yet recruiting - MRI Scan Clinical Trials

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

Start date: May 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This phase 1b open label, dose-escalating investigation study is to evaluate the dose dependent initial efficacy of the use of MT218 injection for biomarker targeted MR molecular imaging (MRMI) of prostate cancer in patients scheduled for radical prostatectomy.

NCT ID: NCT06262126 Recruiting - Chest Pain Clinical Trials

Virtual Reality for Non-cardiac Chest Pain

Start date: February 14, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).

NCT ID: NCT06262113 Not yet recruiting - Neurofibromatosis 1 Clinical Trials

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Start date: November 2024
Phase: N/A
Study type: Interventional

The goal of this fully decentralized, randomized controlled trial is to compare the efficacy of two educational interventions for individuals with Neurofibromatosis 1 (NF1). The primary objective of the study is to determine which intervention leads to higher rates of evidenced-based health screenings for NF1 patients in primary care settings. Adults with NF1 and parents/guardians of children with NF1 from across the U.S. who do not go to a specialized NF clinic and who have an upcoming annual wellness visits scheduled with a primary care provider (PCP) are eligible to enroll in the study.

NCT ID: NCT06261957 Recruiting - Asthma Clinical Trials

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants 12 Years of Age and Older With Asthma

Start date: May 31, 2024
Phase: Phase 3
Study type: Interventional

The goal of this study is to assess and compare the safety and tolerability of salbutamol administered via metered dose inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged 12 years and above with asthma.

NCT ID: NCT06261905 Recruiting - Opioid Use Disorder Clinical Trials

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Start date: March 13, 2024
Phase: Phase 1
Study type: Interventional

The research team is investigating Opioid Use Disorder (OUD), a disorder characterized by dysregulated dopaminergic tone, to evaluate the mechanisms of adjunctive treatment with calcitriol. The investigators will recruit 12 subjects with OUD and 12 healthy subjects to participate in a double-blind, randomized study design where subjects will complete up to 2 Positron Emission Tomography (PET) scans using [11C]-PHNO. The investigators will compare subjects in differences between their own study days and in differences between healthy control subjects and subjects with OUD.

NCT ID: NCT06261814 Not yet recruiting - Liver Neoplasms Clinical Trials

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Start date: August 31, 2024
Phase: Phase 2
Study type: Interventional

This phase II trial evaluates the diagnostic performance of contrast-enhanced ultrasound (CEUS) for assessing treatment response in patients undergoing transarterial chemoembolization (TACE) for liver tumors. TACE is a hepatic artery embolization technique involving the injection of a blocking agent and a chemotherapy agent to treat liver cancers. Currently, contrast enhanced magnetic resonance imaging or computed tomography are used to assess disease response 1-2 months after TACE treatment, but ultrasound may be a less expensive, earlier alternative. CEUS is an imaging procedure that uses high-frequency sound waves to generate images of the body after administering lumason, an imaging agent used to enhance visualization of blood flow on ultrasounds. CEUS is able to be performed during the TACE procedure, making it possible to evaluate treatment response earlier than standard techniques. CEUS may be an effective method to evaluate treatment response more accurately and much earlier than current standard evaluation methods.

NCT ID: NCT06261775 Active, not recruiting - Healthy Lifestyle Clinical Trials

Effect of Minimally Processed Animal Protein on Biomarkers for Cognitive Decline

Start date: January 30, 2024
Phase: N/A
Study type: Interventional

Minimally processed animal protein is a premier source of essential macro and micronutrients in the diet and is important, especially to older adults who are at increased risk of nutritional deficiency and age-related physiological changes. Our central hypothesis is that adding lean animal protein within a dietary guideline-based diet will enhance nutrient adequacy and attenuate markers of cognitive decline. This is a retrospective study leveraging samples collected from the feeding trial NCT05581953. PI for both studies are the same.

NCT ID: NCT06261736 Recruiting - Clinical trials for Stress Urinary Incontinence

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

Start date: October 24, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

NCT ID: NCT06261619 Recruiting - Airway Management Clinical Trials

Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

Effective respiratory ventilation is achieved by moving the right amount of air to and out of the lungs while keeping the pressures at a safe level. A disposable safety device, Adult Sotair®, was created to improve manual ventilation delivery. In this superiority study, the investigators will perform two-group cross over randomized design to test the superiority of the Adult Sotair® device compared to manual ventilation alone.